$182M
$247,000
0.0% of portfolio
17
Q3 2022
New
$0
$11.8 Million
0.0% of portfolio
4,664
Q4 2017
Reduced 22.56%
$0
$33.7 Million
0.0% of portfolio
8,831
Q1 2020
Added 5.89%
$1.32B
$54.7 Million
0.0% of portfolio
674
Q1 2020
Reduced 91.69%
$29M
$1.93 Million
0.0% of portfolio
5,500
Q3 2022
New
$779M
$385,000
0.0% of portfolio
12
Q1 2020
Added 16.67%
$2.49B
$1.27 Million
0.0% of portfolio
45
Q4 2019
Added 3,822.22%
$2.87M
$154,000
0.0% of portfolio
52
Q2 2020
Added 197.37%
$2.67B
$22.9 Million
0.0% of portfolio
291
Q1 2020
Reduced 81.79%
$48.3B
$40.8 Million
0.0% of portfolio
692
Q2 2020
Added 15.4%
$1.21B
$29.3 Million
0.0% of portfolio
9,637
Q4 2021
Reduced 86.51%
$12.5B
$61.4 Million
0.0% of portfolio
684
Q2 2020
Added 23.16%
$0
$14.7 Million
0.0% of portfolio
1,655
Q2 2020
Added 1.85%
$33.3B
$6.01 Million
0.0% of portfolio
30
Q2 2020
Added 11,853.33%
$0
$15.3 Million
0.0% of portfolio
275
Q2 2020
Reduced 22.8%
$0
$71.5 Million
0.0% of portfolio
2,820
Q2 2022
Added 9.04%
$2.05B
$17.8 Million
0.0% of portfolio
316
Q2 2020
Reduced 46.53%
$272M
$20.3 Million
0.0% of portfolio
1,000
Q1 2020
Added 5.0%
$7.17B
$77.6 Million
0.0% of portfolio
6,446
Q2 2020
Added 19.31%
$7.71B
$41.8 Million
0.0% of portfolio
1,699
Q2 2020
Added 0.15%
$166M
$4.44 Million
0.0% of portfolio
200
Q3 2022
New
$0
$4.25 Million
0.0% of portfolio
340
Q4 2017
Added 517.65%
$2.61B
$4 Million
0.0% of portfolio
55
Q1 2019
Added 18.67%
$42.2B
$77.1 Million
0.0% of portfolio
1,693
Q2 2020
Added 4.38%
$0
$1.29 Million
0.0% of portfolio
67
Q2 2020
Reduced 14.67%
$0
$750,000
0.0% of portfolio
60
Q1 2020
Reduced 80.0%
$89.4M
$404,000
0.0% of portfolio
500
Q1 2021
Added 179.0%
$0
$106 Million
0.0% of portfolio
3,981
Q2 2021
Reduced 92.46%
$19.3M
$1.93 Million
0.0% of portfolio
650
Q3 2022
New
$2.52B
$10.8 Million
0.0% of portfolio
411
Q1 2020
Reduced 66.67%
$24.1B
$80 Million
0.0% of portfolio
380
Q2 2020
Reduced 88.36%
$58.8B
$83.5 Million
0.0% of portfolio
39
Q2 2020
Reduced 38.66%
$1.12B
$26.9 Million
0.0% of portfolio
1,237
Q2 2020
Reduced 33.8%
$18B
$106 Million
0.0% of portfolio
652
Q2 2020
Reduced 0.3%
$247M
$11.8 Million
0.0% of portfolio
432
Q1 2020
Reduced 50.0%
$3.8B
$104 Million
0.0% of portfolio
700
Q4 2017
Reduced 40.0%
$3.27B
$87.8 Million
0.0% of portfolio
1,450
Q1 2020
Reduced 82.76%
$3.96B
$4.91 Million
0.0% of portfolio
110
Q4 2020
Reduced 31.82%
$108M
$1.28 Million
0.0% of portfolio
200
Q4 2019
Reduced 97.5%
$816M
$5.24 Million
0.0% of portfolio
2,300
Q4 2021
Reduced 83.7%
$63B
$2.94 Million
0.0% of portfolio
660
Q2 2020
Added 815.03%
$83.5B
$46.4 Million
0.0% of portfolio
20,000
Q2 2020
Added 1,536.36%
$1.86B
$7.92 Million
0.0% of portfolio
244
Q4 2017
Added 136.89%
$4.97B
$56.8 Million
0.0% of portfolio
1,437
Q2 2020
Added 126.9%
$0
$97.4 Million
0.0% of portfolio
3,450
Q1 2019
Reduced 98.55%
$0
$44.1 Million
0.0% of portfolio
1,625
Q4 2020
Added 50.22%
$302M
$3.64 Million
0.0% of portfolio
2,000
Q3 2022
New
$1.8B
$21.4 Million
0.0% of portfolio
450
Q4 2020
Reduced 59.78%
Bellicum Pharmaceuticals Inc
-
$12,000
0.0% of portfolio
-
Q3 2022
New
$1.47B
$21.4 Million
0.0% of portfolio
1,700
Q2 2020
Reduced 41.18%